P. Hoffman et al., CLOPIDOGREL ENHANCEMENT OF RT-PA THROMBOLYSIS IN A THROMBOEMBOLIC MODEL OF CEREBRAL-ISCHEMIA IN RATS, FIBRINOLYSIS & PROTEOLYSIS, 12(2), 1998, pp. 97-105
Citations number
38
Categorie Soggetti
Hematology,Biology,"Medicine, Research & Experimental
Objective: The effects of postembolic treatment with clopidogrel-a thi
enopyridine derivative and inhibitor of platelet aggregation-alone and
in combination with rt-PA were investigated in a thromboembolic model
of monofocal cerebral ischemia in rats. Methods: After injection of a
single in vitro prefabricated fibrin-rich autologous macroclot (400 m
u m x 4 mm) into the internal carotid artery of Sprague Dawley rats, t
he animals were assigned to one of four intravenous treatment groups:
(1) continuous saline infusion over 45 min starting 60 min after embol
ization (control); (2) rt-PA as a continuous infusion at 6 mg/kg for 4
5 min starting 60 min after embolization; (3) clopidogrel at 20 mg/kg
immediately after embolization followed by a continuous saline infusio
n for 45 min starting 60 min after injection; (4) rt-PA as in group 2
plus clopidogrel as in group 3. Results: Embolization produced occlusi
ons of the ipsilateral middle cerebral artery or the internal carotid
artery at the origin of the middle cerebral artery. Occlusions were st
able in the control group. Administration of rt-PA at a thrombolytic t
hreshold dose together with clopidogrel resulted in a recanalization o
f the middle cerebral artery as demonstrated by angiographic control i
mmediately after treatment. Recanalization was associated with a decre
ase in the neurological deficit (30% vs control) and in the subcortica
l and total infarct volumes (18 and 25%) at 24 h albeit the difference
s did not attain significance. No gross intracranial hemorrhages were
observed following clopidogrel/rt-PA coadministration. Postembolic tre
atment with clopidogrel alone tended to reduce infarct volume and to i
mprove neurological outcome. Tail transection bleeding time was prolon
ged in the clopidogrel group (4.7-fold) and in both rt-PA-treated grou
ps (> g-fold). Ex vivo platelet aggregation was inhibited by clopidogr
el treatment but not by rt-PA infusion. Conclusion: These data provide
evidence for the first time that rt-PA thrombolysis after ischemic st
roke can be enhanced by adjunctive postembolic antiplatelet therapy. T
his effect was not accompanied by gross intracranial hemorrhages.